Pfizer Limited — Others, 11-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Pfizer Limited has announced a board meeting on the compliance with Regulation 74(5) of SEBI regarding dematerialization of shares for the quarter and year ended March 31, 2025. KFin Technologies confirmed that securities received for dematerialization have been properly verified and listed accordingly. This update reflects Pfizer's adherence to regulatory requirements and effective management of its equity structure.

For investors, this underscores a commitment to operational transparency and governance, which could be viewed positively as it reinforces confidence in the company's operations.